Errata: Corrigendum Volume 18, Issue 2, 387, Article first published online: 25 January 2013
Conflict of Interest statement: HR has been on advisory boards for AstraZeneca, GlaxoSmithKline and Novartis, has received speaker's honoraria from GlaxoSmithKline, AstraZeneca, Merck and Getz Pharma, has provided consultancy services for Biota and GlaxoSmithKline, and has received research funding from GlaxoSmithKline and AstraZeneca. None of the other authors have any conflict of interest to declare.
Helen K. Reddel, Woolcock Institute of Medical Research, PO Box M77, Missenden Road Post Office, Sydney, NSW 2050, Australia. Email: email@example.com